Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant

被引:120
作者
Kreiss, K
Mroz, MM
Zhen, BG
Wiedemann, H
Barna, B
机构
[1] NATL JEWISH CTR IMMUNOL & RESP MED,DIV ENVIRONM & OCCUPAT MED,DENVER,CO 80206
[2] UNIV COLORADO,HLTH SCI CTR,DEPT PREVENT MED & BIOMETR,DENVER,CO 80262
[3] CLEVELAND CLIN,CLEVELAND,OH 44106
关键词
beryllium; occupational lung disease; lymphocyte proliferation test; surveillance; exposure-response;
D O I
10.1136/oem.54.8.605
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives-To describe relative hazards in sectors of the beryllium industry, risk factors of beryllium disease and sensitisation related to work process were sought in a beryllium manufacturing plant producing pure metal, oxide, alloys, and ceramics. Methods-AU 646 active employees were interviewed; beryllium sensitisation was ascertained with the beryllium lymphocyte proliferation blood test on 627 employees; clinical evaluation and bronchoscopy were offered to people with abnormal test results; and industrial hygiene measurements related to work processes taken in 1984-93 were reviewed. Results-59 employees (9.4%) had abnormal blood tests, 47 of whom underwent bronchoscopy. 24 new cases of beryllium disease were identified, resulting in a beryllium disease prevalence of 4.6%, including five known cases (29/632). Employees who had worked in ceramics had the highest prevalence of beryllium disease (9.0%). Employees in the pebble plant (producing beryllium metal) who had been employed after 1983 also had increased risk, with a prevalence of beryllium disease of 6.4%, compared with 1.3% of other workers hired in the same period, and a prevalence of abnormal blood tests of 19.2%. Logistic regression modelling confirmed these two risk factors for beryllium disease related to work processes and the dependence on time of the risk at the pebble plant. The pebble plant was not associated with the highest gravimetric industrial hygiene measurements available since 1984. Conclusion-Further characterisation of exposures in beryllium metal production may be important to understanding how beryllium exposures confer high contemporary risk of beryllium disease.
引用
收藏
页码:605 / 612
页数:8
相关论文
共 11 条
[1]  
FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1
[2]   EPIDEMIOLOGY OF BERYLLIUM SENSITIZATION AND DISEASE IN NUCLEAR WORKERS [J].
KREISS, K ;
MROZ, MM ;
ZHEN, BG ;
MARTYNY, JW ;
NEWMAN, LS .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04) :985-991
[3]  
Kreiss K, 1996, AM J IND MED, V30, P16, DOI 10.1002/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO
[4]  
2-Q
[5]  
KREISS K, 1993, J OCCUP ENVIRON MED, V35, P267
[6]   REEXAMINATION OF THE BLOOD LYMPHOCYTE-TRANSFORMATION TEST IN THE DIAGNOSIS OF CHRONIC BERYLLIUM DISEASE [J].
MROZ, MM ;
KREISS, K ;
LEZOTTE, DC ;
CAMPBELL, PA ;
NEWMAN, LS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (01) :54-60
[7]  
*NAT MAT ADV BOARD, 1989, NMAB452
[8]   PATHOLOGIC AND IMMUNOLOGICAL ALTERATIONS IN EARLY STAGES OF BERYLLIUM DISEASE - RE-EXAMINATION OF DISEASE DEFINITION AND NATURAL-HISTORY [J].
NEWMAN, LS ;
KREISS, K ;
KING, TE ;
SEAY, S ;
CAMPBELL, PA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (06) :1479-1486
[9]   HLA-DPB1 GLUTAMATE-69 - A GENETIC-MARKER OF BERYLLIUM DISEASE [J].
RICHELDI, L ;
SORRENTINO, R ;
SALTINI, C .
SCIENCE, 1993, 262 (5131) :242-244
[10]   TRANS-BRONCHOSCOPIC LUNG-BIOPSY IN SARCOIDOSIS - OPTIMAL NUMBER AND SITES FOR DIAGNOSIS [J].
ROETHE, RA ;
FULLER, PB ;
BYRD, RB ;
HAFERMANN, DR .
CHEST, 1980, 77 (03) :400-402